Odyssey Therapeutics Net Profit Margin Growth & History (ODTX)
Odyssey Therapeutics's net profit margin was 0.00% for fiscal 2025.
View full Odyssey Therapeutics company overviewOdyssey Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.00% | — |
| 2023 | 2023-12-31 | −12,144.46% | — |
Odyssey Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −4,299.79% | — |
| Q1 2025 | 2025-03-31 | −2,003.91% | — |
| Q4 2024 | 2024-12-31 | −2,047.41% | — |
Odyssey Therapeutics net profit margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Odyssey Therapeutics's net profit margin increased from −12,144.46% to 0.00%, a change of +12144.46 percentage points. The latest reported quarter, Q2 2025, shows −4,299.79%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Odyssey Therapeutics source filings ↗